Overview
miDiagnostics develops miniaturized diagnostic devices that bring laboratory-quality testing closer to the patient. The compact form factor targets point-of-care settings where traditional lab infrastructure is unavailable or where speed of results is critical.
The $31.5M Series D, closed in December 2024, funds scaling of manufacturing and commercial operations. Alychlo, the investment vehicle of Marc Coucke, is among the backers, adding a prominent Belgian investor to the cap table.
The Series D stage indicates the company has moved past early clinical validation and is focused on commercial expansion.
Funding & milestones
4 events found for miDiagnostics · 2020–2024
Venture roundVenture / equity1 sourceEUR 14M
Reported amount EUR 14,000,000
Company confirms completed €14m investment round; investors include new Rudi Pauwels and VMF Invest.
Venture roundVenture / equity1 sourceEUR 38M
Reported amount EUR 38,000,000
Company release separates €38m new capital round from €20m EIB loan; €58m headline not treated as equity.
Debt1 sourceEUR 20M
Reported amount EUR 20,000,000
Company announces granted €20m EIB loan; same loan anticipated April 2021, recorded once.
ParticipantsEuropean Investment BankSeries DVenture / equity1 sourceEUR 30M
Reported amount EUR 30,000,000
Company confirms completed €30m round led by Thermo Fisher.
Recorded history so far. Original currencies are preserved; amounts in different currencies are not added together. Debt, grants, acquisitions and listings are separate event types. Undated events appear last.
Profile narrative
- Series D: $31.5M (December 2024)
Key people
In the news
- Vlaamse miljonairs moeten miDiagnostics alweer stutten05:05 Hoewel al ruim 200 miljoen euro in miDiagnostics werd gepompt, moeten de familiale geldschieters (Marc Coucke, Urbain Vandeurzen, Michel Akkermans) het medtechbedrijf opnieuw stutten. MiDiagnostics mo...
De Tijd Durfkapitaal · 3 Jul 2026
- We're incredibly proud to share that miDiagnostics has been awarded MedTech Company of the Year – Breakthrough Diagnostic Technology | Europe in Business Worldwide Magazine's 2026 Global Corporate Excellence Awards. 🤝 This recognition reflects the dedication, expertise, and passion of our entire team. Every day, we work toward one goal: helping accelerate access to life-changing therapies through faster, reliable diagnostic solutions. ⭐ This recognition becomes even more meaningful with the acknowledgment of our CEO, Dr.
Backers
- AAlychlo
Marc Coucke's family office, investing across tech, pharma, and food from a base in Merelbeke.
Something wrong or missing? Send an update. Fixed within 24 hours.